LEGN

Legend Biotech Corporation - ADR

18.27

USD

LEGN Earnings Reports

Positive Surprise Ratio

LEGN beat 9 of 20 last estimates.

45%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

$313.95M

-$0.06

Implied change from Q3 25 (Revenue/ EPS)

+15.28%

-72.73%

Implied change from Q4 24 (Revenue/ EPS)

+68.32%

-140.00%

Legend Biotech Corporation - ADR earnings per share and revenue

On Nov 12, 2025, LEGN reported earnings of -0.22 USD per share (EPS) for Q3 25, missing the estimate of -0.08 USD, resulting in a -155.52% surprise. Revenue reached 272.33 million, compared to an expected 277.95 million, with a -2.02% difference. The market reacted with a -2.67% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 313.95 million USD, implying an decrease of -72.73% EPS, and increase of 15.28% in Revenue from the last quarter.

FAQ

What were Legend Biotech Corporation - ADR's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Legend Biotech Corporation - ADR reported EPS of -$0.22, missing estimates by -155.52%, and revenue of $272.33M, -2.02% below expectations.

How did the market react to Legend Biotech Corporation - ADR's Q3 2025 earnings?

The stock price moved down -2.67%, changed from $32.03 before the earnings release to $31.18 the day after.

When is Legend Biotech Corporation - ADR expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Legend Biotech Corporation - ADR's next earnings report?

Based on 18 analysts, Legend Biotech Corporation - ADR is expected to report EPS of -$0.06 and revenue of $313.95M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.